CD Protein Inhibitors Immunotherapy Tyrosine Kinase Inhibitors Cyclin Dependent Kinase Inhibitors Serine-Threonine Kinase Inhibitors Chemotherapy Kinase Inhibitors IGF Epigenetics | Melanoma | Acute Lymphocytic Leukemia | Hepatocellular Cancer | B Acute Lymphoblastic Leukemia | Gastric Adenocarcinoma | Diffuse Large B Cell Lymphoma | Prolymphocytic Leukemia | Estrogen Receptor Positive Breast Cancer | Ewing Sarcoma | Renal Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | HER2 Positive Breast Cancer | Mantle Cell Lymphoma | Gallbladder Cancer | Glioma | Pancreatic Cancer |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
blinatumomab | ||||||||||||||||
palbociclib | ||||||||||||||||
palbociclib + JQ-1 | ||||||||||||||||
ibrutinib | ||||||||||||||||
vincristine + lomustine + procarbazine hydrochloride | ||||||||||||||||
palbociclib + VRx-510 | ||||||||||||||||
ribociclib + VRx-510 | ||||||||||||||||
ASP7487 | ||||||||||||||||
temsirolimus | ||||||||||||||||
abemaciclib + tucatinib | ||||||||||||||||
alemtuzumab | ||||||||||||||||
Immunotherapy | ||||||||||||||||
T-lymphocyte cell therapy | ||||||||||||||||
BET inhibitor + CDK inhibitor |